Novo Nordisk
NVO
#110
Rank
NZ$315.65 B
Marketcap
NZ$71.62
Share price
-3.12%
Change (1 day)
-14.76%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Quarterly Reports

Thumbnail Novo Nordisk Quarterly Report 2021-q1

Quarterly Report 2021-q1

Language: English

View Quarterly Report
Thumbnail Novo Nordisk Quarterly Report 2020-q1

Quarterly Report 2020-q1

Language: English

View Quarterly Report